Get the Stockscreener App
0.5585
7.01%
-0.0421
Pre-market:
.59
0.0315
+5.64%
Century Therapeutics Inc Stock (IPSC) Forecast
The Century Therapeutics Inc (IPSC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $12.65, representing a +2,165% increase from the current price of $0.5585. The highest analyst price target is $12.46, and the lowest is $12.84.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IPSC Price Target
Average 9.2686
(+1,560% Upside)
Is Century Therapeutics Inc (IPSC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 24.11 | Buy |
| STOCH(9,6) | 19.90 | Buy |
| STOCHRSI(14) | 23.71 | Neutral |
| MACD(12,26) | -0.0654 | Sell |
| ADX(14) | 45.68 | Sell |
| William %R | -95.82 | Buy |
| CCI(14) | -81.62 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.6189
Sell
|
0.6217
Sell
|
| MA20 |
0.6751
Sell
|
0.6679
Sell
|
| MA50 |
0.8072
Sell
|
0.8153
Sell
|
| MA100 |
1.0731
Sell
|
1.0684
Sell
|
| MA200 |
1.6108
Sell
|
1.574
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, IPSC could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on IPSC, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 24.11 indicates that IPSC is oversold. This indicates that IPSC price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 19.9 indicates that IPSC is oversold. This indicates that IPSC price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 23.71 indicates that IPSC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 45.68 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -81.62 indicates that IPSC is still oversold but not to an extreme extent.
Long-term IPSC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Century Therapeutics Inc financial reports and earnings history, Century Therapeutics Inc (IPSC) stock could reach $14.43 by 2030, $140.92 by 2040 and $207.16 by 2050. See the projected annual prices until 2050 of the Century Therapeutics Inc stock below:
- Century Therapeutics Inc (IPSC) is expected to reach an average price of $62.32 in 2035, with a high prediction of $63.78 and a low estimate of $62.90. This indicates an $11,058% rise from the last recorded price of $0.5585.
- Century Therapeutics Inc (IPSC) stock is projected to chart a bullish course in 2040, with an average price target of $141.41, representing an $25,220% surge from its current level. The forecast ranges from a conservative $11.59 to a sky-high $140.92.
- Our analysts predict Century Therapeutics Inc (IPSC) to jump 16,078% by 2045, soaring from $90.61 to an average price of $90.36, potentially reaching $92.61. While $90.61 is the low estimate, the potential upside is significant.
- Century Therapeutics Inc (IPSC) stock is expected to climb by 2050, reaching an average of $204.83, a $36,574% jump from its current level. However, a wide range of estimates exists, with high and low targets of $207.16 and $205.17, respectively, highlighting the market's uncertainty.
Century Therapeutics Inc Stock (IPSC) Year by Year Forecast
Century Therapeutics Inc Stock (IPSC) Price Forecast for 2025
Century Therapeutics Inc Stock (IPSC) is expected to reach an average price of $9.2686 in 2025, with a high prediction of $12.46 and a low estimate of $6.0784. This indicates an +1,560% rise from the last recorded price of $0.5585.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $12.19 | $12.84 | $12.46 | +2,083% |
| May, 2025 | $10.70 | $12.02 | $11.34 | +1,817% |
| June, 2025 | $7.7962 | $9.2012 | $9.2743 | +1,296% |
| July, 2025 | $8.2092 | $7.7474 | $8.2086 | +1,370% |
| August, 2025 | $8.1617 | $8.3869 | $7.9011 | +1,361% |
| September, 2025 | $6.6342 | $7.6442 | $7.5223 | +1,088% |
| October, 2025 | $6.0872 | $6.5472 | $6.2804 | +989.92% |
| November, 2025 | $8.6397 | $6.0784 | $6.2747 | +1,447% |
| December, 2025 | $10.57 | $10.34 | $10.22 | +1,793% |
Century Therapeutics Inc Stock (IPSC) Price Forecast for 2026
The predicted value for Century Therapeutics Inc (IPSC) in 2026 is set at an average of $7.904. Estimates vary from a peak of $10.29 to a trough of $5.5146, indicating an +1,315% surge from the present price of $0.5585.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $10.05 | $10.07 | $10.29 | +1,699% |
| February, 2026 | $9.1976 | $9.5076 | $9.5758 | +1,547% |
| March, 2026 | $9.8001 | $9.9001 | $9.5701 | +1,655% |
| April, 2026 | $9.3732 | $9.4332 | $9.6013 | +1,578% |
| May, 2026 | $8.6556 | $8.9056 | $8.6358 | +1,450% |
| June, 2026 | $7.7981 | $8.0881 | $8.3462 | +1,296% |
| July, 2026 | $7.3911 | $7.4211 | $7.6593 | +1,223% |
| August, 2026 | $7.0636 | $7.1136 | $7.0967 | +1,165% |
| September, 2026 | $6.7167 | $6.7467 | $6.8542 | +1,103% |
| October, 2026 | $6.6941 | $6.6979 | $6.5991 | +1,099% |
| November, 2026 | $5.9316 | $6.2216 | $6.4697 | +962.05% |
| December, 2026 | $5.4746 | $5.5146 | $5.8828 | +880.24% |
Century Therapeutics Inc Stock (IPSC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Century Therapeutics Inc (IPSC) is $17.55, with a high forecast of $35.10 and a low forecast of $0.00627. This indicates an +3,043% increase from the last price of $0.5585.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.9371 | $3.7671 | $4.3252 | +425.89% |
| February, 2027 | $1.3995 | $1.8195 | $2.3477 | +150.59% |
| March, 2027 | $0.9826 | $0.872 | $1.0101 | +75.93% |
| April, 2027 | $0.815 | $0.155 | $1.205 | +45.92% |
| May, 2027 | $0.3625 | $0.00627 | $1.2133 | -35.09% |
| June, 2027 | $25.85 | $0.05 | $25.36 | +4,528% |
| July, 2027 | $29.34 | $31.53 | $31.43 | +5,154% |
| August, 2027 | $30.14 | $31.36 | $31.06 | +5,297% |
| September, 2027 | $31.20 | $32.89 | $34.29 | +5,486% |
| October, 2027 | $35.16 | $31.90 | $31.78 | +6,196% |
| November, 2027 | $34.46 | $35.54 | $34.43 | +6,069% |
| December, 2027 | $36.29 | $35.76 | $35.10 | +6,398% |
Century Therapeutics Inc Stock (IPSC) Price Forecast for 2028
In 2028, Century Therapeutics Inc (IPSC) is projected to reach an average price of $29.39, with a high projection of $35.82 and a low estimate of $22.97. This indicates an +5,163% rise from the last price of $0.5585.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $36.07 | $36.04 | $35.82 | +6,358% |
| February, 2028 | $33.52 | $34.44 | $34.91 | +5,902% |
| March, 2028 | $33.10 | $33.15 | $32.53 | +5,826% |
| April, 2028 | $32.05 | $32.46 | $33.09 | +5,639% |
| May, 2028 | $33.79 | $34.08 | $34.08 | +5,950% |
| June, 2028 | $32.12 | $32.62 | $33.26 | +5,652% |
| July, 2028 | $29.33 | $31.86 | $31.72 | +5,151% |
| August, 2028 | $26.85 | $26.91 | $28.47 | +4,708% |
| September, 2028 | $25.66 | $26.92 | $27.06 | +4,494% |
| October, 2028 | $26.34 | $26.42 | $26.11 | +4,617% |
| November, 2028 | $23.84 | $24.05 | $25.13 | +4,169% |
| December, 2028 | $22.42 | $22.97 | $22.31 | +3,914% |
Century Therapeutics Inc Stock (IPSC) Price Forecast for 2029
The 2029 price forecast for Century Therapeutics Inc Stock (IPSC) is $20.30 on average, with a high prediction of $25.70 and a low estimate of $14.89. This represents an +3,534% increase from the previous price of $0.5585.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $26.19 | $22.38 | $25.41 | +4,590% |
| February, 2029 | $25.42 | $25.55 | $25.70 | +4,451% |
| March, 2029 | $24.00 | $24.40 | $25.05 | +4,198% |
| April, 2029 | $23.84 | $23.42 | $23.63 | +4,168% |
| May, 2029 | $22.79 | $23.10 | $23.01 | +3,981% |
| June, 2029 | $21.35 | $21.55 | $22.29 | +3,722% |
| July, 2029 | $20.05 | $20.22 | $20.72 | +3,490% |
| August, 2029 | $18.92 | $18.94 | $19.50 | +3,287% |
| September, 2029 | $17.43 | $17.51 | $18.30 | +3,021% |
| October, 2029 | $16.41 | $16.53 | $17.03 | +2,838% |
| November, 2029 | $15.44 | $15.51 | $16.04 | +2,665% |
| December, 2029 | $14.86 | $14.89 | $15.14 | +2,561% |
Century Therapeutics Inc Stock (IPSC) Price Forecast for 2030
Century Therapeutics Inc Stock (IPSC) is expected to reach an average price of $32.15 in 2030, with a high forecast of $61.43 and a low forecast of $2.8599. This signifies an +5,656% surge from the last price of $0.5585.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $13.37 | $13.47 | $14.43 | +2,293% |
| February, 2030 | $11.09 | $12.09 | $12.86 | +1,886% |
| March, 2030 | $9.0054 | $9.0354 | $10.12 | +1,512% |
| April, 2030 | $6.6403 | $6.8903 | $7.7166 | +1,089% |
| May, 2030 | $5.6564 | $5.854 | $5.9215 | +912.79% |
| June, 2030 | $3.6213 | $3.6513 | $5.0076 | +548.40% |
| July, 2030 | $3.5775 | $3.585 | $3.2325 | +540.55% |
| August, 2030 | $59.89 | $2.8599 | $54.25 | +10,624% |
| September, 2030 | $57.30 | $60.15 | $59.85 | +10,159% |
| October, 2030 | $64.09 | $59.29 | $58.83 | +11,375% |
| November, 2030 | $56.53 | $58.56 | $61.43 | +10,021% |
| December, 2030 | $58.95 | $58.73 | $58.95 | +10,456% |
1.39%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):